Updated Pediatric Guidelines Nod to Tivicay for Infants

Updated Pediatric Guidelines Nod to Tivicay for Infants

On April 7, the Department of Health and Human Services released its latest updated treatment guidelines for children and infants with HIV. The Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection were last updated in 2019. Here are more details:Specifically, the guidelines recommend Tivicay PD, a water-dispersible tablet, for treatment-experienced infants and children at least 4 weeks old, in combination with two nucleoside reverse transcriptase inhibitors (NRTIs). This is a change from the previous guidelines, which limited that treatment to children at least 3 years old. The Food and Drug Administration approved the dispersible tablet for infants in June 2020.for infants in June 2020.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!